Transition Therapeutics (TTHI) Promotes Nicole Rusaw-George to CFO
Tweet
Share
E-mailGet Alerts TTHI Hot Sheet
Join SI Premium – FREE
Transition Therapeutics Inc. (Nasdaq: TTHI) has appointed Nicole Rusaw-George, C.A., as Chief Financial Officer of Transition.
George has been with the Company since 2005 and has served as Vice-President, Finance since 2008. While at Transition, George has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
George has been with the Company since 2005 and has served as Vice-President, Finance since 2008. While at Transition, George has been responsible for a broad range of activities with a focus on financial reporting and regulatory compliance as well as involvement in various equity financings and strategic acquisitions.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- Getty Realty discloses separation terms for departing accounting officer
- Sky Quarry names Heidi Bowman as CFO
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
